e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
Genetics and immunobiology of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparison of an assay based on RD1 selected peptides with commercially available assays based on RD1 overlapping peptides to identify subjects with active TB
D. Goletti, S. Carrara, D. Vincenti, O. Butera, F. Bizzoni, M. Amicosante, C. Saltini, E. Girardi (Rome, Italy)
Source:
Annual Congress 2005 - Genetics and immunobiology of tuberculosis
Session:
Genetics and immunobiology of tuberculosis
Session type:
Oral Presentation
Number:
272
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Goletti, S. Carrara, D. Vincenti, O. Butera, F. Bizzoni, M. Amicosante, C. Saltini, E. Girardi (Rome, Italy). Comparison of an assay based on RD1 selected peptides with commercially available assays based on RD1 overlapping peptides to identify subjects with active TB. Eur Respir J 2005; 26: Suppl. 49, 272
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
An assay based on RD1 selected peptides for the diagnosis of extra-pulmonary and smear negative tuberculosis
Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Year: 2008
A new immune diagnostic assay based on ESAT-6 and CFP-10 epitopes in the evaluation of subjects with a clinical suspicion of active tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 427s
Year: 2004
The role of a new immuno-diagnostic test based on ESAT-6 epitopes in the screening of subjects with a clinical suspicion of active tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 166s
Year: 2003
Comparison of ELISPOT and whole-blood assays for IFN-gamma in the immune diagnosis of tuberculosis using ESAT-6 and CFP-10 selected peptides
Source: Eur Respir J 2004; 24: Suppl. 48, 206s
Year: 2004
New tools to discriminate active from past tuberculosis: comparison of the response to RD1 antigens vs latency antigens
Source: Annual Congress 2009 - Frontiers in the diagnosis of tuberculosis
Year: 2009
Monitoring of ESAT-6/CFP-10 selected peptides response during prophylaxis in individuals exposed to
M. tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 363s
Year: 2006
Negative effect of ferritin levels on T-SPOT.TB, an enzyme-linked immunospot based interferon-gamma release assay using Mycobacterium tuberculosis specific antigens, in the smear-positive active pulmonary tuberculosis.
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018
IFN-gamma production in response to RD1 assays correlate with TST size and with the frequency of exposure to the index case in contacts recently exposed to
mycobacterium tuberculosis
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007
Design of immunogenic multiepitopic
mycobacterium tuberculosis
peptides from genes selected using
in vitro
models of mycobacterial macrophage infection
Source: Eur Respir J 2007; 30: Suppl. 51, 493s
Year: 2007
Evaluation of rapid test device based on detection of antibodies against 6,16 and 38 kDa antigens of mycobacterium tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Pre-clinical study of specific activity and specificity of recombinant diagnostic preparation DIASKINTEST based on proteins ESAT-6 and CFP10 in guinea-pigs infected with
M. tuberculosis
Source: Annual Congress 2010 - Scientific advances in tuberculosis
Year: 2010
Comparison of whole-blood interferon-gamma release assay and tuberculin skin test results for the prediction of active tuberculosis disease in HIV-infected individuals
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009
Comparative evaluation of the rapid diagnostic assays for detecting tuberculosis (TB) in a reference center for drug resistant TB in Brazil
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Comparison of T-cell interferon-γ release assay to mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009
Response to
M. tuberculosis
selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
IFN-gamma response on T-cell based assays in HIV patients for detection of tuberculosis infection
Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease
Year: 2008
Sequential analysis of interferon-γ release assay results in active tuberculosis patients
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Improved performances of the Quantiferon-TB in tube assay with novel mycobacterium tuberculosis specific antigenic peptides
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
A set of microRNA markers of active tuberculosis.
Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis
Year: 2020
Evaluation of TB antibodies using ELISA and M. tuberculosis DNA using PCR in children and adolescents from high-prevalence regions
Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept